Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 56 | $10,192,923 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Sep 2024 19:23 | BTAI | BioXcel Therapeutics Inc | YOCCA FRANK | Chief Scientific Officer | 16 Sep 2024 | Sale | 355 | 0.6893 | 245 | D |
17 Sep 2024 19:21 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 16 Sep 2024 | Sale | 1,150 | 0.6905 | 794 | D |
17 Sep 2024 19:21 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 16 Sep 2024 | Sale | 832 | 0.6885 | 573 | D |
17 Sep 2024 19:21 | BTAI | BioXcel Therapeutics Inc | STEINHART RICHARD I | Chief Financial Officer | 16 Sep 2024 | Sale | 356 | 0.6899 | 246 | D |
17 Sep 2024 19:20 | BTAI | BioXcel Therapeutics Inc | RODRIGUEZ JAVIER | See Remarks | 16 Sep 2024 | Sale | 345 | 0.69 | 238 | D |
17 Sep 2024 19:19 | BTAI | BioXcel Therapeutics Inc | O'NEILL VINCENT | See Remarks | 16 Sep 2024 | Sale | 138 | 0.6908 | 95 | D |
17 Sep 2024 19:18 | BTAI | BioXcel Therapeutics Inc | WILEY MATTHEW T. | Chief Commercial Officer | 16 Sep 2024 | Sale | 215 | 0.6908 | 149 | D |
18 Jun 2024 21:27 | BTAI | BioXcel Therapeutics Inc | YOCCA FRANK | Chief Scientific Officer | 17 Jun 2024 | Sale | 372 | 1.28 | 476 | D |
18 Jun 2024 21:26 | BTAI | BioXcel Therapeutics Inc | WILEY MATTHEW T. | Chief Commercial Officer | 17 Jun 2024 | Sale | 244 | 1.2627 | 308 | D |
18 Jun 2024 21:26 | BTAI | BioXcel Therapeutics Inc | STEINHART RICHARD I | Chief Financial Officer | 17 Jun 2024 | Sale | 372 | 1.2622 | 470 | D |
18 Jun 2024 21:25 | BTAI | BioXcel Therapeutics Inc | RODRIGUEZ JAVIER | See Remarks | 17 Jun 2024 | Sale | 361 | 1.2632 | 456 | D |
18 Jun 2024 21:25 | BTAI | BioXcel Therapeutics Inc | O'NEILL VINCENT | See Remarks | 17 Jun 2024 | Sale | 155 | 1.285 | 199 | D |
18 Jun 2024 21:24 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 17 Jun 2024 | Sale | 2,134 | 1.2835 | 2,739 | D |
06 Jun 2024 20:35 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 05 Jun 2024 | Sale | 126,014 | 1.5841 | 199,619 | I |
06 Jun 2024 20:35 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 04 Jun 2024 | Sale | 126,014 | 1.6309 | 205,516 | I |
06 Jun 2024 20:35 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 04 Jun 2024 | Sale | 283,123 | 0 | 0 | I |
06 Jun 2024 20:35 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 05 Jun 2024 | Sale | 283,122 | 0 | 0 | I |
06 Jun 2024 20:35 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 04 Jun 2024 | Sale | 609,221 | 0 | 0 | I |
08 Apr 2024 19:32 | BTAI | BioXcel Therapeutics Inc | O'NEILL VINCENT | See Remarks | 04 Apr 2024 | Sale | 165 | 2.6211 | 432 | D |
08 Apr 2024 19:32 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 04 Apr 2024 | Sale | 4,439 | 2.6247 | 11,651 | D |
08 Apr 2024 19:32 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 04 Apr 2024 | Sale | 829 | 2.62 | 2,172 | D |
08 Apr 2024 19:32 | BTAI | BioXcel Therapeutics Inc | STEINHART RICHARD I | Chief Financial Officer | 04 Apr 2024 | Sale | 1,069 | 2.635 | 2,817 | D |
08 Apr 2024 19:31 | BTAI | BioXcel Therapeutics Inc | WILEY MATTHEW T. | CHIEF COMMERCIAL OFFICER | 04 Apr 2024 | Sale | 1,008 | 2.6351 | 2,656 | D |
08 Apr 2024 19:30 | BTAI | BioXcel Therapeutics Inc | RODRIGUEZ JAVIER | See Remarks | 04 Apr 2024 | Sale | 1,012 | 2.6358 | 2,667 | D |
08 Apr 2024 19:30 | BTAI | BioXcel Therapeutics Inc | YOCCA FRANK | Chief Scientific Officer | 04 Apr 2024 | Sale | 1,067 | 2.635 | 2,812 | D |
16 Jun 2023 18:40 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 16 Jun 2023 | Sale | 747 | 21.89 | 16,352 | D |
16 Jun 2023 18:40 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 16 Jun 2023 | Sale | 4,266 | 20.9 | 89,159 | D |
16 Jun 2023 18:40 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 16 Jun 2023 | Sale | 24,987 | 20.01 | 499,990 | D |
16 Jun 2023 18:40 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 15 Jun 2023 | Sale | 8,012 | 21.9 | 175,463 | D |
16 Jun 2023 18:40 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 15 Jun 2023 | Sale | 21,988 | 21.41 | 470,763 | D |
24 May 2023 16:37 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 22 May 2023 | Sale | 6,500 | 25.7909 | 167,641 | D |
16 May 2023 20:32 | BTAI | BioXcel Therapeutics Inc | STEINHART RICHARD I | Chief Financial Officer | 15 May 2023 | Sale | 5,000 | 27.1727 | 135,864 | D |
16 May 2023 20:29 | BTAI | BioXcel Therapeutics Inc | RODRIGUEZ JAVIER | See Remarks | 15 May 2023 | Sale | 1,785 | 27.3192 | 48,765 | D |
10 Apr 2023 18:20 | BTAI | BioXcel Therapeutics Inc | NANDABALAN KRISHNAN | Director , 10% | 06 Apr 2023 | Sale | 60,000 | 17.32 | 1,039,200 | D |
22 Mar 2023 19:30 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 21 Mar 2023 | Sale | 900 | 20.15 | 18,135 | D |
22 Mar 2023 19:30 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 21 Mar 2023 | Sale | 29,100 | 19.7 | 573,270 | D |
22 Mar 2023 19:30 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 20 Mar 2023 | Sale | 604 | 18.88 | 11,404 | D |
22 Mar 2023 19:30 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 20 Mar 2023 | Sale | 3,896 | 18.22 | 70,985 | D |
22 Mar 2023 19:30 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 20 Mar 2023 | Sale | 5,333 | 18.86 | 100,580 | D |
22 Mar 2023 19:30 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President | 20 Mar 2023 | Sale | 24,667 | 18.2 | 448,939 | D |
16 Mar 2023 18:02 | BTAI | BioXcel Therapeutics Inc | STEINHART RICHARD I | Chief Financial Officer | 15 Mar 2023 | Sale | 2,084 | 19.5 | 40,638 | D |
16 Mar 2023 18:01 | BTAI | BioXcel Therapeutics Inc | YOCCA FRANK | Chief Scientific Officer | 15 Mar 2023 | Sale | 985 | 19.6911 | 19,396 | D |
16 Mar 2023 17:59 | BTAI | BioXcel Therapeutics Inc | O'NEILL VINCENT | Chief Medical Officer | 15 Mar 2023 | Sale | 845 | 19.695 | 16,642 | D |
16 Mar 2023 17:58 | BTAI | BioXcel Therapeutics Inc | RODRIGUEZ JAVIER | See Remarks | 15 Mar 2023 | Sale | 950 | 19.625 | 18,644 | D |
24 Jan 2023 20:08 | BTAI | BioXcel Therapeutics Inc | YOCCA FRANK | Chief Scientific Officer | 20 Jan 2023 | Sale | 50,000 | 30 | 1,500,000 | D |
24 Jan 2023 20:04 | BTAI | BioXcel Therapeutics Inc | O'NEILL VINCENT | Chief Medical Officer | 20 Jan 2023 | Sale | 29,713 | 30 | 891,390 | D |
06 Jan 2023 20:00 | BTAI | BioXcel Therapeutics Inc | NANDABALAN KRISHNAN | Director , 10% | 05 Jan 2023 | Sale | 800 | 22.93 | 18,344 | D |
06 Jan 2023 20:00 | BTAI | BioXcel Therapeutics Inc | NANDABALAN KRISHNAN | Director , 10% | 05 Jan 2023 | Sale | 25,089 | 22.32 | 559,986 | D |
06 Jan 2023 20:00 | BTAI | BioXcel Therapeutics Inc | NANDABALAN KRISHNAN | Director , 10% | 04 Jan 2023 | Sale | 9,821 | 22.21 | 218,124 | D |
06 Jan 2023 20:00 | BTAI | BioXcel Therapeutics Inc | NANDABALAN KRISHNAN | Director , 10% | 04 Jan 2023 | Sale | 24,290 | 21.59 | 524,421 | D |
19 Dec 2022 20:00 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 16 Dec 2022 | Sale | 9,887 | 19.92 | 196,949 | D |
19 Dec 2022 20:00 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 16 Dec 2022 | Sale | 20,113 | 19.21 | 386,371 | D |
19 Dec 2022 20:00 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 15 Dec 2022 | Sale | 7,206 | 20.19 | 145,489 | D |
19 Dec 2022 20:00 | BTAI | BioXcel Therapeutics Inc | MEHTA VIMAL | CEO and President, 10% | 15 Dec 2022 | Sale | 22,794 | 19.86 | 452,689 | D |
14 Nov 2022 20:00 | BTAI | BioXcel Therapeutics Inc | NANDABALAN KRISHNAN | Director , 10% | 11 Nov 2022 | Sale | 32,550 | 15 | 488,250 | D |
14 Nov 2022 20:00 | BTAI | BioXcel Therapeutics Inc | NANDABALAN KRISHNAN | Director , 10% | 10 Nov 2022 | Sale | 27,450 | 15 | 411,750 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)